Hehlmann R - Search Results

1

Proliferating status of peripheral blood progenitor cells from patients with BCR/ABL-positive chronic myelogenous leukemia.

Krämer A, Löffler H, Bergmann J, Hochhaus A, Hehlmann R. Krämer A, et al. Among authors: hehlmann r. Leukemia. 2001 Jan;15(1):62-8. doi: 10.1038/sj.leu.2402005. Leukemia. 2001. PMID: 11243401

2

Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group.

Hehlmann R, Heimpel H, Hasford J, Kolb HJ, Pralle H, Hossfeld DK, Queisser W, Löffler H, Hochhaus A, Heinze B, et al. Hehlmann R, et al. Blood. 1994 Dec 15;84(12):4064-77. Blood. 1994. PMID: 7994025 Free article. Clinical Trial.

3

The German CML study, comparison of busulfan vs. hydroxyurea vs. interferon alpha and establishment of prognostic score 1.

Hehlmann R, Heimpel H, Kolb HJ, Heinze B, Hochhaus A, Griesshammer M, Pralle H, Queisser WP, Essers U, Falge C, et al. Hehlmann R, et al. Leuk Lymphoma. 1993;11 Suppl 1:159-68. doi: 10.3109/10428199309047880. Leuk Lymphoma. 1993. PMID: 8251890 Clinical Trial.

4

A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia.

Hochhaus A, Reiter A, Skladny H, Melo JV, Sick C, Berger U, Guo JQ, Arlinghaus RB, Hehlmann R, Goldman JM, Cross NC. Hochhaus A, et al. Among authors: hehlmann r. Blood. 1996 Sep 15;88(6):2236-40. Blood. 1996. PMID: 8822944 Free article.

5

[Chronic myeloid leukemia. Current strategies in diagnosis, therapy and follow-up].

Hochhaus A, Hehlmann R. Hochhaus A, et al. Among authors: hehlmann r. Internist (Berl). 1996 Oct;37(10):1013-21. Internist (Berl). 1996. PMID: 9019445 Review. German. No abstract available.

6

Randomized studies with interferon in chronic myelogenous leukemia (CML) and comparative molecular aspects. German CML Study Group.

Hehlmann R, Willer A, Heimpel H, Hasford J, Kolb HJ, Pralle H, Hossfeld DK, Queisser W, Löffler H, Hochhaus A, Tobler A, Lengfelder E, Berger U, Leib-Mösch C. Hehlmann R, et al. Leukemia. 1997 Apr;11 Suppl 3:506-11. Leukemia. 1997. PMID: 9209440 Clinical Trial.

7

Monitoring the efficiency of interferon-alpha therapy in chronic myelogenous leukemia (CML) patients by competitive polymerase chain reaction.

Hochhaus A, Lin F, Reiter A, Skladny H, Hehlmann R, Goldman JM, Cross NC. Hochhaus A, et al. Among authors: hehlmann r. Leukemia. 1997 Apr;11 Suppl 3:541-4. Leukemia. 1997. PMID: 9209451

8

Molecular monitoring of residual disease in chronic myelogenous leukemia patients after therapy.

Hochhaus A, Reiter A, Skladny H, Reichert A, Saussele S, Hehlmann R. Hochhaus A, et al. Among authors: hehlmann r. Recent Results Cancer Res. 1998;144:36-45. doi: 10.1007/978-3-642-46836-0_5. Recent Results Cancer Res. 1998. PMID: 9304705 Review.

9

Cyclin A1 is predominantly expressed in hematological malignancies with myeloid differentiation.

Krämer A, Hochhaus A, Saussele S, Reichert A, Willer A, Hehlmann R. Krämer A, et al. Among authors: hehlmann r. Leukemia. 1998 Jun;12(6):893-8. doi: 10.1038/sj.leu.2401051. Leukemia. 1998. PMID: 9639417

10

Chronic myelogenous leukemia: molecular and cellular aspects.

Pasternak G, Hochhaus A, Schultheis B, Hehlmann R. Pasternak G, et al. Among authors: hehlmann r. J Cancer Res Clin Oncol. 1998;124(12):643-60. doi: 10.1007/s004320050228. J Cancer Res Clin Oncol. 1998. PMID: 9879825 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

468 results

Search Page

Filters